Press Release

The global pharma and biotech CRM software market revenue surpassed US$ 7.21 billion in 2024 and is predicted to attain around US$ 20.0 billion by 2033, growing at a CAGR of 15.2% during the forecast period from 2025 to 2033.

The growth observed during the historic period in the pharma and biotech CRM software market can be largely attributed to a significant shift towards a customer-centric approach. Organizations are increasingly recognizing the importance of prioritizing customer needs and experiences, which has led to the expansion of sales and marketing channels. Additionally, there has been a marked rise in the demand for data analytics, enabling companies to harness insights that drive informed decision-making and strategy formulation.

As companies strive for greater efficiency and productivity, enhancing the customer experience has become paramount. In response to the growing expectations set by global health authorities, both biotech firms and established pharmaceutical companies are increasingly adopting multi-feature CRM solutions. These systems provide comprehensive capabilities that streamline various functions, from medical affairs to sales analytics, ultimately improving operational workflows and customer interactions.

Pharma and Biotech CRM Software Market Key Takeaways

• The pharma & biotech CRM software market is projected to experience substantial growth, with revenue expected to surge from US$ 7.21 billion in 2024 to US$ 20.0 billion by 2033. This represents a remarkable compound annual growth rate (CAGR) of 15.2% during the forecast period from 2025 to 2033.
• In terms of deployment, cloud-based CRM solutions are leading the market, holding more than 57.78% of the market share. The preference for cloud-based systems is largely due to their ability to reduce IT complexity, facilitate real-time data exchange, and promote simplified global collaboration.
• When considering enterprise size, large enterprises dominate the pharma & biotech CRM software market, capturing over 57.1% of the market share. This dominance stems from their need for robust architectures that seamlessly integrate R&D reporting, manage global sales operations, and adhere to stringent compliance requirements.
• In terms of industry segmentation, pharmaceutical companies hold a significant advantage in the CRM software market, commanding over 65% of the market share compared to their biotech counterparts. This lead is primarily attributed to their broader commercial portfolios and well-established brand presence.

North America Accounted for 44.45% of Revenue Share

North America holds a significant position in the Pharma & biotech CRM software market, commanding over 44.45% of the overall market share. This regional dominance can be attributed to a robust healthcare infrastructure coupled with vibrant research hubs throughout the United States and Canada. In 2024, it was reported that the United States alone maintains an impressive drug development pipeline, which includes a multitude of clinical trials focused on areas such as oncology, immunology, and rare diseases.

This extensive array of clinical activities generates a substantial demand for CRM platforms that facilitate the management of investigator relationships, coordinate field sales efforts, and oversee post-approval marketing initiatives. The need for efficient data management and streamlined communication is paramount in this environment, leading to an increased reliance on sophisticated CRM solutions.

One notable example is the Oracle Cloud CX solutions, which are frequently adopted by leading pharmaceutical manufacturers in North America. These solutions enable companies to centralize their cross-departmental processes, enhancing collaboration and efficiency. As the market continues to evolve, the Americas are expected to remain at the forefront of CRM software adoption in the pharmaceutical and biotech sectors, driven by innovation and a commitment to advancing healthcare outcomes.

Market Overview

The pharmaceutical and biotech CRM software market encompasses the development of software solutions specifically designed to assist pharmaceutical and biotechnology companies in managing their customer relationships effectively. This market is experiencing rapid growth and is projected to continue expanding as organizations seek more efficient and reliable methods for coordinating data. 

Several key factors are driving this growth, including an increasing patient population linked to the rising incidence of chronic and acute diseases, a surge in client engagement activities, and the overall expansion of the pharmaceutical industry. A recent article titled "Validity Launches 2022 State of CRM Data Health Report highlights significant trends affecting the CRM landscape. The report is based on a survey conducted with over 1,200 CRM users and stakeholders from the United States, United Kingdom, and Australia. 

According to the findings, 57% of respondents anticipate an increase in their company's data management budgets for 2022. Furthermore, 56% of those without dedicated personnel for CRM data quality are planning to hire full-time employees within the next six months. These insights underscore a growing recognition of the importance of data quality and management within organizations.

Pharma and Biotech CRM Software Market Growth Factors

Driver

Demand for Compliance-Focused CRM Solutions: In regulatory-intensive environments, such as the pharmaceutical and biotechnology sectors, the demand for compliance-focused Customer Relationship Management (CRM) solutions has surged. These industries operate under stringent regulations imposed by governmental agencies, including the Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in Europe. As organizations navigate complex regulatory landscapes, they require CRM systems that not only streamline operations but also ensure adherence to compliance standards throughout the lifecycle of drug development and commercialization.

Adoption of CRM to Streamline Clinical Data Coordination: The adoption of Customer Relationship Management (CRM) systems is becoming increasingly essential for organizations involved in clinical research and drug development, particularly as the complexity of clinical data coordination continues to rise on a global scale.  

Restraint

Integration Issues:  Integrating legacy laboratory systems with modern Customer Relationship Management (CRM) platforms poses a myriad of challenges that can hinder operational efficiency and data integrity within pharmaceutical organizations. This incompatibility can lead to difficulties in data exchange, resulting in fragmented information repositories and inefficient workflows. 

Data Security Concerns: As pharmaceutical companies increasingly turn to cloud-based CRM solutions, they face several pressing data security concerns that require careful consideration. One of the foremost issues is the potential exposure of sensitive data. Pharmaceutical organizations handle confidential patient information, clinical trial data, and proprietary research findings. 

Top Trends

AI-Driven CRM Solutions: The landscape of drug development for rare diseases is unique and often challenging due to the limited patient populations and the complexities involved in clinical trials. AI-driven Customer Relationship Management (CRM) solutions have emerged as vital tools tailored specifically for this sector. These advanced systems utilize machine learning algorithms and data analytics to provide insights that enhance decision-making and streamline processes.

Increased Adoption of Cloud-Based CRM: The shift towards remote work has accelerated the adoption of cloud-based CRM solutions, particularly in industries like healthcare and pharmaceuticals. These platforms offer several advantages that support effective remote collaboration:

Recent Developments

• In December 2024, Veeva Systems unveiled two innovative generative AI tools: Vault CRM Bot and Vault CRM Voice Control. These additions reflect the company's dedication to boosting productivity within the life sciences sector.
• In November 2024, DKSH Healthcare and Euris introduced ConnectPlus, an all-in-one Customer Relationship Management (CRM) and Multi-Channel Engagement (MCE) platform. This transformative solution aims to revolutionize healthcare distribution across the APAC region. By leveraging data and agility, ConnectPlus enhances efficiency through a comprehensive overview of healthcare professionals and streamlines omnichannel engagement strategies.

Pharma and Biotech CRM Software Market Companies Major Players:

• Oracle Corporation
• QuintilesIMS
• Veeva Systems
• Salesforce
• Aurea
• bpm'online
• Euris
• Indegene
• Infonis International
• Interactive Medica
• Media-soft Inc.
• Navicon
• Synergistix
• TrueBlue
• Pitcher Inc.
• Prolifiq
• StayinFront
• Cirrius
• Other Prominent Players

Key Segmentation:

By Deployment

• On-Premise
• Cloud-Based (SaaS)

By Enterprise Size

• Large Enterprise
• Small & Medium Enterprise

By Industry

• Pharmaceuticals
• Biotech

By Technology

• AI CRM
• Conventional CRM

By Geography

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa (MEA)